NCT06451692 · RECRUITING

Prioritising Patient Medication Review: Hospitals Reaching Out

This trial is testing whether having a clinical pharmacist review the medications of older hospital patients taking seven or more drugs at once leads to better outcomes. It focuses on people 65 and older admitted to either a short-stay unit or a medical outpatient clinic in Denmark. This is a Phase NA study, meaning it is evaluating a care process rather than a drug, so the usual phase labels do not apply.

You may qualify if

  • all hospitalized patients who are prescribed at least seven medications specified in the Electronic Patient Journal (EPJ) at admission

You're excluded if

  • terminal patients or patients with a short life expectancy, patients residing in another region, patients who are discharged on the day of inclusion, and finally patients who do not speak Danish.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-13

View full record on ClinicalTrials.gov

All APOE4 clinical trials